Ever-Rising Fatty Liver Disease Gets Its First Drug and a New Name

A drug that targets liver scarring from fatty liver disease gained Food and Drug Administration accelerated approval in March, marking the first-ever drug specifically for the disease to get the FDA’s nod. Experts hope the medication, designated a “breakthrough therapy,” proves to be a sign of more treatments to come.


Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks